Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
acute myeloid leukemia
adverum biotechnologies
ally bridge group
ambit biosciences
athena countouriotis
big data analytics
blackrock
boston
boston blog main
boston top stories
brett zbar
bristol-myers squibb
casdin capital
clinical trials
cormorant asset management
daiichi sankyo
diabetic nephropathy
eventide asset management
focal segmental glomerulosclerosis
goldfinch bio
halozyme therapeutics
hbm healthcare investments
hbm partners
irving investors
jay ghosh
jean cui
lilly asia ventures
nextech invest
orbimed advisors
peter li
pfizer
quizartinib
repotrectinib
robert adelman
san diego
san diego blog main
What
biotech
2
×
drug
2
×
million
new
raised
2
×
analysis
athena
bio
bring
cancer
ceo
chief
company
countouriotis
develop
diseases
employing
financing
genetic
gets
goldfinch
ipo
kidney
later
lead
medical
medicines
mezzanine
names
officer
old
promoted
push
raises
round
studies
therapeutics
tp
year
Language
unset
Current search:
biotech
×
raised
×
drug
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
